Grant Opportunities Archives - Page 3 of 6 - BioHealth Innovation

Grant Opportunities

Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (SBIR)(R43/R44)- Jan 07, 2016

... Funding Opportunity Number: PA-13-092 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: Health CFDA Number: 93.351…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 16, 2013

Grant Opportunities

NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)

... Funding Opportunity Number: PAR-13-278 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Health CFDA Number:…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserJuly 22, 2013

Grant Opportunities

NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)

... Funding Opportunity Number: PAR-13-250 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Health CFDA Number:…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserJune 27, 2013

Grant Opportunities

Revolutionary Genome Sequencing Technologies The $1000 Genome (R01)

Funding Opportunity Number: RFA-HG-13-005 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.172Eligible Applicants State governmentsCounty governmentsCity…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserJune 27, 2013

Grant Opportunities

Revolutionary Genome Sequencing Technologies The $1000 Genome (SBIR [R43/R44])

Funding Opportunity Number: RFA-HG-13-007 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthCFDA Number: 93.172Eligible Applicants Small businessesAgency Name:…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserJune 27, 2013

Grant Opportunities

Research to Characterize and Reduce Stigma to Improve Health (R01) – Sep 07, 2016

... Funding Opportunity Number: PA-13-248 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: EducationHealth CFDA Number: 93.17293.17393.24293.39393.39493.39593.39693.39793.39893.39993.85393.866…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserJune 18, 2013

Grant Opportunities

Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01)

(more…)

<img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

BHI AdministratorMay 9, 2013

Grant Opportunities

Broad Agency Announcement (BAA): Adjuvant Discovery Program, BAA-NIAID-DAIT-NIH-AI-2013168

(more…)

<img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

BHI AdministratorMay 9, 2013

Grant Opportunities

Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (SBIR)(R43/R44) – May 07, 2016

(more…)

<img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

BHI AdministratorMay 9, 2013

Grant Opportunities

National Cooperative Reprogrammed Cell Research Groups (NCRCRG) to Study Mental Illness (U19) – Jan 07, 2016

(more…)

<img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' data-src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='BHI Administrator' src='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/5d952c98d7bca5600d03df3aa602efeb?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

BHI AdministratorMay 9, 2013

Previous 1 2 3 4 5 6 Next

© 2024 BioHealth Innovation.